share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga ·  Mar 7 05:31

Gainers

  • SCWorx (NASDAQ:WORX) stock increased by 60.8% to $2.75 during Wednesday's after-market session. The market value of their outstanding shares is at $3.3 million.
  • IO Biotech (NASDAQ:IOBT) stock increased by 11.44% to $1.85. The company's market cap stands at $121.8 million. As per the press release, Q4 earnings came out yesterday.
  • Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 8.11% to $1.6. The market value of their outstanding shares is at $5.1 million.
  • NextCure (NASDAQ:NXTC) shares increased by 8.01% to $1.82. The market value of their outstanding shares is at $50.7 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares moved upwards by 7.47% to $0.75. The market value of their outstanding shares is at $76.4 million.
  • Telesis Bio (NASDAQ:TBIO) stock moved upwards by 4.99% to $0.51. The market value of their outstanding shares is at $15.4 million.

Losers

  • Nexalin Technology (NASDAQ:NXL) shares fell 14.4% to $0.45 during Wednesday's after-market session. The market value of their outstanding shares is at $3.2 million.
  • Avalo Therapeutics (NASDAQ:AVTX) shares decreased by 12.04% to $4.53. The market value of their outstanding shares is at $3.6 million.
  • HeartBeam (NASDAQ:BEAT) shares declined by 11.97% to $1.43. The market value of their outstanding shares is at $37.5 million.
  • Trxade Health (NASDAQ:MEDS) shares declined by 10.7% to $15.45. The market value of their outstanding shares is at $18.6 million.
  • Vicarious Surgical (NYSE:RBOT) stock declined by 9.34% to $0.31. The market value of their outstanding shares is at $54.7 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Creative Medical Tech (NASDAQ:CELZ) stock fell 8.62% to $4.35. The market value of their outstanding shares is at $6.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment